James J. MacDonald - 18 Feb 2022 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & General Counsel
Signature
/s/ James J. MacDonald
Issuer symbol
SANA
Transactions as of
18 Feb 2022
Net transactions value
+$16,141
Form type
4
Filing time
23 Feb 2022, 16:01:50 UTC
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $18,232 +1,000 +0.23% $18.23 429,750 15 Nov 2021 Direct F1, F2
transaction SANA Common Stock Sale $2,091 -333 -0.08% $6.28 429,417 18 Feb 2022 Direct F3
holding SANA Common Stock 7,812 18 Feb 2022 Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10
holding SANA Common Stock 125,000 18 Feb 2022 Held by the KOM Trust
holding SANA Common Stock 125,000 18 Feb 2022 Held by the NMM Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the "Issuer") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 3, 2021 through November 15, 2021. This transaction is exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021.
F3 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.